Last updated on February 2019
Study to Assess Efficacy and Safety of Baloxavir Marboxil In Combination With Standard-of-Care Neuraminidase Inhibitor In Hospitalized Participants With Severe Influenza
Brief description of study
This study will evaluate the efficacy, safety, and pharmacokinetics of baloxavir marboxil in combination with a standard-of-care (SOC) neuraminidase inhibitor (NAI) (i.e., oseltamivir, zanamivir, or peramivir) compared with a matching placebo in combination with a SOC NAI in hospitalized patients with influenza.
Clinical Study Identifier: NCT03684044
Start Over
Reference Study ID Number: CP40617 ...
Multiprofile Hospital for Active Treatment Sveta Petka AD; Department of Pneumology and Phtysiatrics Vidin, Bulgaria3.0miles
Connect »